Share Email Print

Journal of Biomedical Optics • Open Access

Effect of tissue optics on wavelength optimization for quantum dot-based surface and subsurface fluorescence imaging
Author(s): Mathieu Roy; Anthony Kim; Brian C. Wilson; Farhan N. Dadani; Carolyn Niu

Paper Abstract

Optimization is an important but relatively unexplored aspect of contrast-enhanced fluorescence imaging, since minimizing contrast agent usage reduces the associated cost and potential toxicity. In a previous study, the authors developed a quantitative experimental approach to optimize quantum dot (QD)-based imaging using homogenized liver as a model tissue. In this follow-up study, the authors further extend and validate the approach using eight different tissues and five QDs emission wavelengths, and introduce quantitative imaging performance metrics, namely the threshold QD concentration and wavelength optimization gain. These metrics allow quantification of the improvements through spectral optimization in terms of reduced QD dose and identify the conditions that make the optimization process worthwhile. The authors show that, for most tissues, the most important parameter to optimize is the emission wavelength, yielding improvements of up to four orders of magnitude, followed by the excitation wavelength (up to 20-fold improvement) and the excitation filter bandwidth (up to 50% improvement). The authors also observe, by means of the optimization gain metric, that tissues exhibiting both high autofluorescence and strong pigmentation are generally better candidates for excitation wavelength optimization. This work contributes to the development of robust and quantitative dosimetry for QD-based fluorescence imaging near to the tissue surface.

Paper Details

Date Published: 5 March 2012
PDF: 13 pages
J. Biomed. Opt. 17(2) 026002 doi: 10.1117/1.JBO.17.2.026002
Published in: Journal of Biomedical Optics Volume 17, Issue 2
Show Author Affiliations
Mathieu Roy, Ontario Cancer Institute (Canada)
Anthony Kim, Ontario Cancer Institute (Canada)
Brian C. Wilson, Ontario Cancer Institute (Canada)
Farhan N. Dadani, Ontario Cancer Institute (Canada)
Carolyn Niu, Ontario Cancer Institute (Canada)

© SPIE. Terms of Use
Back to Top